StonvexLoading…
StonvexStonvexStonvexCore line items from ASAN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $790.81M | $585.24M | $384.20M | $187.27M |
Operating Income | $-197.33M | $-163.35M | $-93.36M | $-43.90M |
Net Income | $-189.02M | $-156.81M | $-88.38M | $-40.02M |
EPS (Diluted) | $-0.80 | $-0.66 | $-0.38 | $-0.17 |
Total Assets | $844.09M | $840.43M | $883.16M | $877.13M |
Total Liabilities | $689.97M | $652.07M | $658.60M | $640.83M |
Cash & Equivalents | $199.84M | $183.47M | $184.15M | $193.79M |
Free Cash Flow OCF − CapEx | $86.57M | $60.17M | $44.66M | $6.13M |
Shares Outstanding | 236.82M | 236.31M | 235.55M | 234.86M |